Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Pharmaceuticals & Biotech
Create a narrative
Merck KGaA Community
XTRA:MRK Community
1
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Create a narrative
Merck KGaA
Popular
Undervalued
Overvalued
Community Investing Ideas
Merck KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics
Key Takeaways Merck KGaA's Life Science and Electronics sectors are poised for growth, driven by strong customer demand and AI advancements in semiconductors. Strategic investments in CapEx and M&A aim to enhance efficiencies, with oncology driving Healthcare growth through external partnerships.
View narrative
€169.38
FV
28.0% undervalued
intrinsic discount
3.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Your Valuation for
MRK
MRK
Merck KGaA
Your Fair Value
€
Current Price
€121.90
46.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
25b
2015
2018
2021
2024
2025
2027
2030
Revenue €25.3b
Earnings €3.3b
Advanced
Set Fair Value